Vicente Ballester-Gimeno
Zaragoza, AR 50009, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
External validation of population pharmacokinetic models of adalimumab in adult patients with inflammatory bowel disease: towards model-informed precision dosing.
Journal: Journal of pharmacokinetics and pharmacodynamics
Published: January 22, 2026
Pharmacokinetic insights into atezolizumab SC: viability of extended dosing intervals beyond the standard regimen.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: October 01, 2025
Lung immune prognostic index (LIPI) as a prognostic factor in patients with extensive-stage small cell lung cancer treated with first-line chemoimmunotherapy.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: July 25, 2024
[Translated article] The role of artificial intelligence in scientific publishing: perspectives from hospital pharmacy.
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: May 07, 2024
INES: Interactive tool for construction and extrapolation of partitioned survival models.
Journal: Cost effectiveness and resource allocation : C/E
Published: May 02, 2023
Cost-effectiveness analysis of the first-line EGFR-TKIs in patients with advanced EGFR-mutated non-small-cell lung cancer.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: October 04, 2021
Olaparib as first line in BRCA-mutated advanced ovarian carcinoma: Is it cost-effective in Spain?
Journal: Gynecologic oncology
Published: June 17, 2021
Dacomitinib in first-line treatment of advanced EGFR-mutated non-small-cell lung cancer: a cost-effectiveness analysis.
Journal: Journal of comparative effectiveness research
Published: February 26, 2021
Analysis of first-line treatment in older patients with metastasic colorectal cancer.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: January 12, 2021
Network meta-analysis of first-line treatments in transplant-ineligible multiple myeloma patients.
Journal: European journal of haematology
Published: January 12, 2020
Osimertinib in first-line treatment of advanced EGFR-mutated non-small-cell lung cancer: a cost-effectiveness analysis.
Journal: Journal of comparative effectiveness research
Published: September 04, 2019
Last Updated: 09/26/2026